Otsuka Holdings

Update in progress

4578.T (Tokyo)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Otsuka Holdings Co., Ltd. is a global, diversified company focused on pharmaceuticals, nutraceuticals, and consumer products. It develops medicines across psychiatry, neurology, oncology, cardiovascular/renal, autoimmune and digestive diseases, and ophthalmology, and provides diagnostics, intravenous solutions, medical devices, clinical testing, analytical equipment, and health foods. It also offers IT solutions, logistics, venture investments, and related services. Founded 1921; headquartered in Chiyoda, Tokyo.

Company score

Sentiment: 0.48; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.14; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.44; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.14; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.20; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.34; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive